Mehala Subramanieapillai, MSc
- 2Articles
- 34.5KReads
- 2019–2020Active
- 5Collaborators
- 198Citations
About
Mehala Subramanieapillai, MSc, has published research on the use of oral ketamine in the treatment of major depressive disorder (MDD). Contributions include a systematic review and a correction related to oral ketamine for depression. Subramanieapillai's work appears in Psychiatrist.com, collaborating frequently with Andre F. Carvalho, Joshua D. Rosenblat, Madeline Li, Roger S. McIntyre, and Yena Lee.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
